Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,282 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.
Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ; VIGOR Study Group. Bombardier C, et al. Among authors: day r. N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528. doi: 10.1056/NEJM200011233432103. N Engl J Med. 2000. PMID: 11087881 Clinical Trial.
A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis. OMERACT Drug Safety Working Party.
Lipani JA, Strand V, Johnson K, Woodworth T, Furst D, Singh G, Day R, Brooks P; OMERACT Drug Safety Working Party. Lipani JA, et al. Among authors: day r. J Rheumatol. 2001 May;28(5):1170-3. J Rheumatol. 2001. PMID: 11361208 Review.
Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a rheumatologist's perspective.
Day RO. Day RO. Clin Exp Rheumatol. 2001 Nov-Dec;19(6 Suppl 25):S59-62. Clin Exp Rheumatol. 2001. PMID: 11695254 Review.
Another selective COX-2 inhibitor: more questions than answers?
Day R. Day R. J Rheumatol. 2002 Aug;29(8):1581-2. J Rheumatol. 2002. PMID: 12180711 Review. No abstract available.
Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity Index.
Welch V, Singh G, Strand V, Fries J, Boers M, Ramey D, Day RO, Brooks P, Tugwell P, Clinch J, Kristjansson B. Welch V, et al. Among authors: day ro. J Rheumatol. 2001 May;28(5):1188-91. J Rheumatol. 2001. PMID: 11361211 Review.
A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis.
Lipani JA, Strand V, Woodworth T, Furst D, Singh G, Johnson K, Day R, Brooks P. Lipani JA, et al. Among authors: day r. J Rheumatol. 2000 Apr;27(4):827-30. J Rheumatol. 2000. PMID: 10782801 No abstract available.
An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the knee.
Strand V, Conaghan PG, Lohmander LS, Koutsoukos AD, Hurley FL, Bird H, Brooks P, Day R, Puhl W, Band PA. Strand V, et al. Among authors: day r. Osteoarthritis Cartilage. 2006 Sep;14(9):859-66. doi: 10.1016/j.joca.2006.02.012. Epub 2006 Apr 19. Osteoarthritis Cartilage. 2006. PMID: 16626978
Hypertension in the patient with arthritis: have we been underestimating its significance?
Day R. Day R. J Rheumatol. 2003 Apr;30(4):642-5. J Rheumatol. 2003. PMID: 12672178 Review. No abstract available.
Dichotomy between regulation of coral bacterial communities and calcification physiology under ocean acidification conditions.
Shore A, Day RD, Stewart JA, Burge CA. Shore A, et al. Among authors: day rd. Appl Environ Microbiol. 2021 Jan 8:AEM.02189-20. doi: 10.1128/AEM.02189-20. Online ahead of print. Appl Environ Microbiol. 2021. PMID: 33419736
A survey of Australian public attitudes towards funding of high cost cancer medicines.
Ghinea N, Critchley C, Morrell B, Kerridge I, Campbell T, Day R, Gazarian M, Isaacs D, Liauw W, Olver I, Pace J, Pearson S, Salkeld G, Lipworth W. Ghinea N, et al. Among authors: day r. Health Policy. 2020 Dec 10:S0168-8510(20)30301-8. doi: 10.1016/j.healthpol.2020.12.002. Online ahead of print. Health Policy. 2020. PMID: 33402264
2,282 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback